ASH 2023: MRD Highlights in BioPharma Drug Development

Read More

Tumor-Infiltrating Merkel Cell Polyomavirus-Specific T Cells Are Diverse and Associated with Improved Patient Survival

Miller et al.
Cancer Immunology Research
Papers
February 2017
Authors and Affiliates
Natalie J. Miller1, Candice D. Church1, Lichun Dong2, David Crispin3, Matthew P. Fitzgibbon3, Kristina Lachance1, Lichen Jing2, Michi Shinohara1, Ioannis Gavvovidis4,5, Gerald Willimsky5,6, Martin McIntosh3, Thomas Blankenstein4,5,7, David M. Koelle2,8,9, and Paul Nghiem1 1Dermatology/Medicine/Pathology, University of Washington, Seattle, Washington. 2Department of Medicine/Laboratory Medicine/Global Health, University of Washington, Seattle, Washington. 3Fred Hutchinson, Public Health Sciences Division, Seattle, Washington. 4Molecular Immunology and Gene Therapy, Max-Delbrück-Center for Molecular Medicine, Berlin, Germany. 5Institute of Immunology, Charit e, Berlin, Germany. 6German Cancer Research Center (DKFZ), Heidelberg, Germany. 7Berlin Institute of Health, Berlin, Germany. 8Fred Hutchinson, Vaccine and Infectious Disease Division, Seattle, Washington. 9Benaroya Research Institute, Seattle, Washington.